1168 related articles for article (PubMed ID: 30453528)
1. Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.
Peter J; Fournier C; Keip B; Rittershaus N; Stephanou-Rieser N; Durdevic M; Dejaco C; Michalski M; Moser G
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453528
[TBL] [Abstract][Full Text] [Related]
2. A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome.
Peter J; Fournier C; Durdevic M; Knoblich L; Keip B; Dejaco C; Trauner M; Moser G
Psychosom Med; 2018 Oct; 80(8):698-709. PubMed ID: 30095672
[TBL] [Abstract][Full Text] [Related]
3. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.
Moser G; Trägner S; Gajowniczek EE; Mikulits A; Michalski M; Kazemi-Shirazi L; Kulnigg-Dabsch S; Führer M; Ponocny-Seliger E; Dejaco C; Miehsler W
Am J Gastroenterol; 2013 Apr; 108(4):602-9. PubMed ID: 23419384
[TBL] [Abstract][Full Text] [Related]
4. The structure of resilience in irritable bowel syndrome and its improvement through hypnotherapy: Cross-sectional and prospective longitudinal data.
Peter J; Tran US; Michalski M; Moser G
PLoS One; 2018; 13(11):e0202538. PubMed ID: 30419026
[TBL] [Abstract][Full Text] [Related]
5. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
[TBL] [Abstract][Full Text] [Related]
6. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
7. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.
Hoekman DR; Vlieger AM; Stokkers PC; Mahhmod N; Rietdijk S; de Boer NK; de Meij TG; Frankenhuis C; D'Haens GR; Benninga MA
J Crohns Colitis; 2021 Jul; 15(7):1106-1113. PubMed ID: 33245332
[TBL] [Abstract][Full Text] [Related]
8. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
9. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome.
Naseri K; Dabiri H; Rostami-Nejad M; Yadegar A; Houri H; Olfatifar M; Sadeghi A; Saadati S; Ciacci C; Iovino P; Zali MR
BMC Gastroenterol; 2021 Jul; 21(1):292. PubMed ID: 34261437
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis.
Devenney J; Hasan SS; Morris J; Whorwell PJ; Vasant DH
Aliment Pharmacol Ther; 2024 Jan; 59(2):269-277. PubMed ID: 37927144
[TBL] [Abstract][Full Text] [Related]
11. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
12. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
Lindfors P; Ljótsson B; Bjornsson E; Abrahamsson H; Simrén M
Neurogastroenterol Motil; 2013 Feb; 25(2):169-e86. PubMed ID: 23051178
[TBL] [Abstract][Full Text] [Related]
13. Irritable bowel syndrome and gut microbiota.
Canakis A; Haroon M; Weber HC
Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):28-35. PubMed ID: 31789724
[TBL] [Abstract][Full Text] [Related]
14. [Effect of
Chen L; Xu WL; Pei LX; Wu XL; Geng H; Guo J; Sun JH
Zhongguo Zhen Jiu; 2021 Feb; 41(2):137-41. PubMed ID: 33788460
[TBL] [Abstract][Full Text] [Related]
15. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
Fukudo S
Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158
[TBL] [Abstract][Full Text] [Related]
16. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
[TBL] [Abstract][Full Text] [Related]
17. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
[TBL] [Abstract][Full Text] [Related]
18. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials.
Lindfors P; Unge P; Arvidsson P; Nyhlin H; Björnsson E; Abrahamsson H; Simrén M
Am J Gastroenterol; 2012 Feb; 107(2):276-85. PubMed ID: 21971535
[TBL] [Abstract][Full Text] [Related]
19. Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease.
Peters SL; Muir JG; Gibson PR
Aliment Pharmacol Ther; 2015 Jun; 41(11):1104-15. PubMed ID: 25858661
[TBL] [Abstract][Full Text] [Related]
20. A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels.
Nilholm C; Manoharan L; Roth B; D'Amato M; Ohlsson B
United European Gastroenterol J; 2022 May; 10(4):363-375. PubMed ID: 35484927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
